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The aim of this study was to investigate the effect of rimonabant treatment on
hepatic mitochondrial function in rats fed a high-fat diet. Sprague-Dawley rats fed a
high-fat diet (35% lard) for 13 wk were treated with rimonabant (10
mg·kg−1·day−1) during the last 3 wk and matched with pair-fed controls. Oxygen
consumption with various substrates, mitochondrial enzyme activities on isolated
liver mitochondria, and mitochondrial DNA quantity were determined. Body weight
and fat mass were decreased in rats treated with rimonabant compared with pair-
fed controls. Moreover, the serum adiponectin level was increased with rimonabant.
Hepatic triglyceride content was increased, while serum triglycerides were
decreased. An increase of mitochondrial respiration was observed in rats treated
with rimonabant. The increase of mitochondrial respiration with palmitoyl-CoA
compared with respiration with palmitoyl-l-carnitine stating that the entry of fatty
acids into mitochondria via carnitine palmitoyltransferase I was increased in rats
treated with rimonabant. Moreover, rimonabant treatment led to a reduction in the
enzymatic activity of ATP synthase, whereas the quantity of mitochondrial DNA and
the activity of citrate synthase remained unchanged. To summarize, rimonabant
treatment leads to an improvement of hepatic mitochondrial function by increasing
substrate oxidation and fatty acid entry into mitochondria for the β-oxidation
pathway and by increasing proton leak. However, this increase of mitochondrial
oxidation is regulated by a decrease of ATP synthase activity in order to have only
ATP required for the cell function.
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